# Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver Cirrhosis

> **NCT03130127** · NA · UNKNOWN · sponsor: **General Hospital of Shenyang Military Region** · enrollment: 40 (estimated)

## Conditions studied

- Liver Cirrhosis
- Portal Hypertension
- Variceal Hemorrhage
- Bleeding
- Esophageal and Gastric Varices

## Interventions

- **DRUG:** Terlipressin

## Key facts

- **NCT ID:** NCT03130127
- **Lead sponsor:** General Hospital of Shenyang Military Region
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-07-01
- **Primary completion:** 2025-12-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03130127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03130127, "Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver Cirrhosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03130127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*